Inventor
JR., LAWRENCE S. MELVIN
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61MDevices for introducing media into, or onto, the body23%
A61JContainers specially adapted for medical or pharmaceutical purposes8%
Y02ATechnologies for adaptation to climate change8%
PatentTitleYear
12,171,874Rapamycin for the treatment of lymphangioleiomyomatosis202411,744,797Rapamycin for the treatment of lymphangioleiomyomatosis202311,648,199Inhalable rapamycin formulation for treating age-related conditions202311,491,143Inhalable rapamycin formulation for the treatment of pulmonary hypertension2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to AI THERAPEUTICS INC (3)· patent assignee history
2022–2024Based in US· patent location history
2023Patents assigned to AL THERAPEUTICS INC (2)· patent assignee history
2024Patents assigned to ORPHAI THERAPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AI THERAPEUTICS INC | 3 | 2022–2023 |
| AL THERAPEUTICS INC | 2 | 2023 |
| ORPHAI THERAPEUTICS INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2024 |